1. Case DC, Jr., Sonneborn HL, Paul SD et al. Phase II study of rDNA alpha-2 interferon (INTRON A) in patients with multiple myeloma utilizing an escalating induction phase. Cancer Treat Rep 1986; 70:1251–1254.
2. Clark RH, Dimitrov NV, Axelson JA, and Charmella LJ. Leukocyte interferon as a biological response modifier in lymphoproliferative diseases resistant to standard therapy. Blood 1983; 62:188a (abstract).
3. Cooper MR. Interferons in the treatment of multiple myeloma. Semin Oncol 1986; 13:13–20.
4. Dimopoulos M, Spencer A, Attal M, et al. Lenalidomide plus dex-amethasone for relapsed or refractory multiple myeloma. N Engl Med 2007; 357:2123–2132.
5. Ferraresi R. Enhanced response to chemotherapy after treatment with DNA alpha-2 interferon. Am Soc Hematol 1983; 62:212a.